Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Repressor Proteins | 4 | 2019 | 812 | 0.980 |
Why?
|
| Hemangioma, Cavernous | 1 | 2023 | 20 | 0.820 |
Why?
|
| Cavernous Sinus | 1 | 2023 | 24 | 0.810 |
Why?
|
| Hemangioma | 1 | 2023 | 97 | 0.760 |
Why?
|
| Inclusion Bodies | 1 | 2021 | 42 | 0.690 |
Why?
|
| Meningioma | 4 | 2025 | 134 | 0.690 |
Why?
|
| Ataxin-1 | 4 | 2018 | 162 | 0.680 |
Why?
|
| Meningeal Neoplasms | 4 | 2025 | 212 | 0.660 |
Why?
|
| Molecular Imaging | 1 | 2020 | 63 | 0.630 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2021 | 123 | 0.630 |
Why?
|
| Hepatocytes | 1 | 2021 | 237 | 0.620 |
Why?
|
| Intestinal Neoplasms | 1 | 2019 | 39 | 0.610 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 356 | 0.590 |
Why?
|
| Neuroendocrine Tumors | 1 | 2019 | 59 | 0.580 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 240 | 0.560 |
Why?
|
| Transplant Recipients | 1 | 2019 | 227 | 0.530 |
Why?
|
| Graft Rejection | 2 | 2020 | 561 | 0.500 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 447 | 0.480 |
Why?
|
| Liver | 2 | 2021 | 1797 | 0.460 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 1280 | 0.460 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 279 | 0.420 |
Why?
|
| Liver Transplantation | 2 | 2020 | 1103 | 0.420 |
Why?
|
| Stomach Neoplasms | 1 | 2019 | 566 | 0.400 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 729 | 0.400 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 985 | 0.370 |
Why?
|
| Autism Spectrum Disorder | 1 | 2017 | 431 | 0.350 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 1658 | 0.340 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 1381 | 0.330 |
Why?
|
| Biopsy | 4 | 2021 | 1284 | 0.310 |
Why?
|
| Nerve Tissue Proteins | 4 | 2017 | 1133 | 0.300 |
Why?
|
| Glioblastoma | 2 | 2022 | 363 | 0.280 |
Why?
|
| Neurofibromin 2 | 1 | 2025 | 11 | 0.230 |
Why?
|
| Radiation Tolerance | 1 | 2025 | 64 | 0.230 |
Why?
|
| Loss of Function Mutation | 1 | 2025 | 159 | 0.210 |
Why?
|
| Cerebellum | 2 | 2018 | 462 | 0.210 |
Why?
|
| Spinocerebellar Ataxias | 2 | 2018 | 255 | 0.200 |
Why?
|
| Mycorrhizae | 1 | 2022 | 2 | 0.190 |
Why?
|
| Orchidaceae | 1 | 2022 | 2 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3835 | 0.180 |
Why?
|
| Cyanamide | 1 | 2021 | 2 | 0.180 |
Why?
|
| Glycogen Storage Disease | 1 | 2021 | 9 | 0.180 |
Why?
|
| Sinusitis | 1 | 2022 | 119 | 0.180 |
Why?
|
| Glycogen | 1 | 2021 | 53 | 0.170 |
Why?
|
| Polypharmacy | 1 | 2021 | 36 | 0.170 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 337 | 0.170 |
Why?
|
| Humans | 19 | 2025 | 132088 | 0.160 |
Why?
|
| Neoplasm Metastasis | 2 | 2021 | 719 | 0.160 |
Why?
|
| Cytoplasm | 1 | 2021 | 268 | 0.160 |
Why?
|
| Aged | 5 | 2025 | 21409 | 0.160 |
Why?
|
| Demyelinating Diseases | 1 | 2020 | 70 | 0.160 |
Why?
|
| Hepatitis B, Chronic | 1 | 2021 | 86 | 0.160 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 7103 | 0.160 |
Why?
|
| Male | 10 | 2025 | 64937 | 0.160 |
Why?
|
| Hyperplasia | 1 | 2019 | 195 | 0.150 |
Why?
|
| Re-Irradiation | 1 | 2018 | 5 | 0.150 |
Why?
|
| Adult | 6 | 2025 | 31573 | 0.140 |
Why?
|
| Female | 9 | 2025 | 70727 | 0.140 |
Why?
|
| Middle Aged | 5 | 2025 | 28971 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 491 | 0.140 |
Why?
|
| Drosophila melanogaster | 2 | 2014 | 844 | 0.140 |
Why?
|
| Glioma | 1 | 2022 | 530 | 0.140 |
Why?
|
| Dietary Supplements | 1 | 2021 | 439 | 0.140 |
Why?
|
| Age of Onset | 1 | 2019 | 623 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2020 | 305 | 0.130 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 111 | 0.130 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 672 | 0.130 |
Why?
|
| ras Proteins | 2 | 2018 | 146 | 0.130 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 91 | 0.130 |
Why?
|
| RNA Splicing Factors | 1 | 2016 | 53 | 0.130 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 293 | 0.120 |
Why?
|
| Nerve Degeneration | 1 | 2016 | 129 | 0.120 |
Why?
|
| Frontotemporal Dementia | 1 | 2016 | 71 | 0.120 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 227 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 176 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1953 | 0.110 |
Why?
|
| Retrospective Studies | 4 | 2022 | 17423 | 0.110 |
Why?
|
| rab1 GTP-Binding Proteins | 1 | 2014 | 3 | 0.110 |
Why?
|
| Dimethylallyltranstransferase | 1 | 2014 | 4 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 2146 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2021 | 14753 | 0.110 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2014 | 50 | 0.100 |
Why?
|
| Protein Subunits | 1 | 2014 | 171 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 37 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 200 | 0.090 |
Why?
|
| Receptors, Notch | 1 | 2014 | 212 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 1379 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 361 | 0.090 |
Why?
|
| Neoplasm Grading | 2 | 2025 | 300 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2020 | 5165 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2018 | 1960 | 0.080 |
Why?
|
| Intellectual Disability | 1 | 2017 | 1087 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2013 | 1116 | 0.080 |
Why?
|
| Mice | 5 | 2018 | 18510 | 0.080 |
Why?
|
| Animals | 7 | 2024 | 34889 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1738 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1977 | 0.070 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 777 | 0.070 |
Why?
|
| Phenotype | 1 | 2017 | 4531 | 0.070 |
Why?
|
| Necrosis | 1 | 2025 | 209 | 0.060 |
Why?
|
| Infant | 1 | 2019 | 13066 | 0.050 |
Why?
|
| Ataxins | 2 | 2013 | 114 | 0.050 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2022 | 24 | 0.050 |
Why?
|
| Dogs | 1 | 2024 | 657 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 3681 | 0.050 |
Why?
|
| Trehalase | 1 | 2022 | 2 | 0.050 |
Why?
|
| Autopsy | 1 | 2022 | 115 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2023 | 114 | 0.050 |
Why?
|
| Trehalose | 1 | 2022 | 20 | 0.050 |
Why?
|
| Child | 2 | 2020 | 25793 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2018 | 3036 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2022 | 257 | 0.040 |
Why?
|
| Symbiosis | 1 | 2022 | 103 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2022 | 257 | 0.040 |
Why?
|
| Adolescent | 1 | 2019 | 20568 | 0.040 |
Why?
|
| Cause of Death | 1 | 2022 | 510 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2020 | 652 | 0.040 |
Why?
|
| Graft Survival | 1 | 2020 | 474 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2022 | 347 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 605 | 0.030 |
Why?
|
| Receptor, Notch1 | 1 | 2018 | 76 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 2058 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2018 | 367 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 688 | 0.030 |
Why?
|
| Radiosurgery | 1 | 2018 | 147 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 207 | 0.030 |
Why?
|
| Mutation | 2 | 2022 | 6230 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1298 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2021 | 745 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2016 | 247 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 2016 | 166 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1574 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 1470 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 4689 | 0.030 |
Why?
|
| Protein Prenylation | 1 | 2014 | 10 | 0.030 |
Why?
|
| Exons | 1 | 2016 | 805 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2018 | 4704 | 0.030 |
Why?
|
| Genomics | 1 | 2021 | 1646 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 101 | 0.020 |
Why?
|
| Dimerization | 1 | 2013 | 149 | 0.020 |
Why?
|
| Protein Stability | 1 | 2013 | 169 | 0.020 |
Why?
|
| Inflammation | 1 | 2020 | 1517 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 2445 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 604 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 338 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 1017 | 0.020 |
Why?
|
| Transgenes | 1 | 2013 | 335 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 309 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2014 | 375 | 0.020 |
Why?
|
| Computational Biology | 1 | 2016 | 874 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 574 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 678 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 5411 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 396 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3864 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 1608 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2669 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 1729 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 4758 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3770 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1610 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2439 | 0.010 |
Why?
|